Results 121 to 130 of about 28,830 (241)

KARAKTERISASI SISTEM BINER EFAVIRENZ-ASAM SITRAT ANHIDRAT

, 2014
Telah dilakukan penelitian pembuatan sistem biner efavirenz-asam sitrat anhidrat serta evaluasi kelarutan dan laju disolusinya. Sistem biner dibuat dengan metode penggilingan (solid state grinding) dan juga dibuat campuran fisiknya.
DIAN, FITRI ANANDA
core  

Efavirenz Plasma Concentrations and HIV Viral Load in HIV/AIDS-tuberculosis Infection Patients Treated with Rifampicin

Acta Medica Indonesiana, 2016
Aim:to determine the effect of a rifampicin-containing tuberculosis regimen on efavirenz plasma concentrations and viral load in HIV/AIDS-Tuberculosis infection patients who received efavirenz-based antiretroviral therapy.
Nina Mariana, Purwantyastuti Purwantyastuti, Instiaty Instiaty, Adria Rusli   +3 more
doaj  

Does tenofovir influence efavirenz pharmacokinetics?

, 2007
INTRODUCTION: A recent report described a possible interaction between tenofovir (TFV) and efavirenz (EFV). Patients developed neuropsychiatric manifestations upon introduction of TFV on a stable EFV-containing regimen.
Colombo, Sara, Rotger, Margalida, Décosterd, Laurent, Furrer, Hansjakob, Telenti, Amalio, Buclin, Thierry   +5 more
core  

Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy/ml

, 2010
Stéphanie Haïm‐Boukobza, Laurence Morand‐Joubert, Philippe Flandre, Nadia Valin, Slim Fourati, Sophie Sayon, Marc Lavignon, Anne Simon, Pierre‐Marie Girard, Christine Katlama, Vincent Cálvez, Anne‐Geneviève Marcelin   +11 more
openalex   +2 more sources

Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection [PDF]

, 2004
Roy M. Gulick, Heather J. Ribaudo, Cecilia M. Shikuma, Stephanie Lustgarten, Kathleen Squires, William A. Meyer, Edward P. Acosta, Bruce R. Schackman, Christopher D. Pilcher, Robert L. Murphy, William E. Maher, Mallory D. Witt, Richard C. Reichman, Sally Snyder, Karin L. Klingman, Daniel R. Kuritzkes   +15 more
openalex   +1 more source

Study the influence of formulation process parameters on solubility and dissolution enhancement of efavirenz solid solutions prepared by hot-melt extrusion: a QbD methodology

, 2018
Jaywant Pawar, Dilipkumar Suryawanshi, Kailas K. Moravkar, Rahul Aware, Vasant Shetty, Mohammed Maniruzzaman, Purnima D. Amin   +6 more
openalex   +2 more sources

One- and Two-Year Outcomes of Switching to a Dolutegravir-Based ART Regimen: An Observational Emulation of Sequential Target Trials. [PDF]

Open Forum Infect Dis
Zheng A, Murray EJ, Brennan AT, Greener R, Kileel EM, Bor J, Venter WDF, Pisa PT, Fox MP, Maskew M.   +9 more
europepmc   +1 more source

Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants [PDF]

, 2017
Katie R. Mollan, Camlin Tierney, Jacklyn N. Hellwege, Joseph J. Eron, Michael G. Hudgens, Roy M. Gulick, Richard Haubrich, Paul E. Sax, Thomas Campbell, Eric S. Daar, Kevin R. Robertson, Diana Ventura, Qing Ma, Digna R. Velez Edwards, David W. Haas   +14 more
openalex   +1 more source

Copper-modified carbon nano-onions as electrode modifiers for the electroanalysis of the antiretroviral drug Efavirenz

, 2023
Kefilwe V. Mokwebo, Eamonn Murphy, Saurav K. Guin, Adalberto Camisasca, Silvia Giordani, Carmel B. Breslin, Emmanuel I. Iwuoha, Eithne Dempsey   +7 more
openalex   +2 more sources

The impact of dolutegravir on the growth of HIV-exposed uninfected infants: an observational cohort study in rural Tanzania. [PDF]

EClinicalMedicine
Glanzmann S, Luoga E, Okuma J, Dotto E, Sigalla G, Franzeck FC, Nyenza E, Mnzava D, Bukuku M, Moshi L, Wilson L, Paris DH, Glass TR, Mollel GJ, Weisser M, Vanobberghen F, KIULARCO Study Group.   +16 more
europepmc   +1 more source